IBT
VCYT icon

International Biotechnology Trust’s Veracyte VCYT Stock Holding History

International Biotechnology Trust’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-170,000
Closed -$1.49M – 69
2017
Q3 		$1.49M Hold
170,000
– – 0.58% 38
2017
Q2 		$1.41M Hold
170,000
– – 0.54% 42
2017
Q1 		$1.56M Buy
+170,000
New +$1.39M 0.6% 36

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

International Biotechnology Trust's VCYT Position: Q4 2017 in Review

International Biotechnology Trust sold out of Veracyte (VCYT) in Q4 2017, closing a stake of 170,000 shares — an estimated $1.49M sold.

International Biotechnology Trust first reported a position in VCYT in Q1 2017 and held it in 3 quarters. The position peaked at $1.56M in Q1 2017. 79 funds tracked by Wall St. Rank hold VCYT as of Q4 2017.

  • International Biotechnology Trust reported no remaining Veracyte position as of Q4 2017 after selling out during the quarter.
  • International Biotechnology Trust sold 170,000 Veracyte shares in Q4 2017, an estimated $1.49M.
  • International Biotechnology Trust first reported a position in Veracyte in Q1 2017 and held it in 3 quarters.
  • International Biotechnology Trust's Veracyte position peaked at $1.56M in Q1 2017.
  • 79 funds tracked by Wall St. Rank held Veracyte as of Q4 2017.

Based on International Biotechnology Trust's 13F filing for Q4 2017, filed 2 Mar 2018.